Derek T. Chalmers, President & CEO at Cara Therapeutics, Inc. (CARA), sold 3,201 shares at $16.00 ($51K) on 2020-09-03, disclosed to the SEC on 2020-09-08.
Open-market sale of $51k CARA by President & CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| CARA | SELL | 2021-03-08 | $112K | — | Filing → |
| CARA | SELL | 2021-02-25 | $453K | — | Filing → |
| CARA | SELL | 2020-12-30 | $186K | — | Filing → |